In recent years, with the interdisciplinary integration of cell biology and materials science, many innovative tumour-targeted therapeutic technologies targeting uPAR have emerged, providing new development directions for precise and efficient tumour therapy. The gene discussed is PLAUR; the disease is neoplasm.